Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,973 | 5,255 | 13,069 | 10,018 | 18,704 |
| Receivables | 13,306 | 24,030 | 22,381 | 14,407 | 18,829 |
| Inventories | 35,290 | 30,772 | 22,848 | 21,351 | 14,667 |
| Other current assets | 376 | 2,301 | 2,295 | 1,280 | 1,665 |
| TOTAL | $80,572 | $72,496 | $72,969 | $49,111 | $58,571 |
| Non-Current Assets | |||||
| PPE Net | 689 | 778 | 899 | 1,221 | 795 |
| Intangibles | 81,598 | 74,417 | 80,655 | 87,251 | 87,015 |
| Other Non-Current Assets | 8,979 | 8,042 | 6,806 | 1,642 | 2,132 |
| TOTAL | $91,266 | $83,237 | $88,360 | $90,114 | $89,942 |
| Total Assets | $171,838 | $155,733 | $161,329 | $139,225 | $148,513 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 36,980 | 15,743 | 42,706 | 15,046 | 10,569 |
| Accounts payable and accrued liabilities | 5,730 | 7,750 | 10,158 | 12,046 | 14,855 |
| Accrued Expenses | 29,742 | 35,482 | 23,257 | 17,128 | 12,575 |
| Other current liabilities | 125 | 2,703 | 2,700 | 2,635 | N/A |
| TOTAL | $97,310 | $66,229 | $83,496 | $48,108 | $39,937 |
| Non-Current Liabilities | |||||
| Long Term Debt | 198 | 34,153 | 27,377 | 39,816 | 34,303 |
| Other Non-Current Liabilities | 22,187 | 25,028 | 28,008 | 31,988 | 53,610 |
| TOTAL | $22,385 | $59,181 | $55,385 | $73,325 | $90,558 |
| Total Liabilities | $119,695 | $125,410 | $138,881 | $121,433 | $130,495 |
| Shareholders' Equity | |||||
| Common Shares | 96,098 | 76,390 | 69,014 | 68,686 | 66,688 |
| Retained earnings | -61,995 | -64,242 | -64,028 | -65,249 | -62,370 |
| Other shareholders' equity | 6,029 | 6,170 | 6,155 | 3,971 | 4,203 |
| TOTAL | $52,143 | $30,323 | $22,448 | $17,792 | $18,018 |
| Total Liabilities And Equity | $171,838 | $155,733 | $161,329 | $139,225 | $148,513 |